These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9699211)

  • 41. Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.
    Oechslin F; Piccardi P; Mancini S; Gabard J; Moreillon P; Entenza JM; Resch G; Que YA
    J Infect Dis; 2017 Mar; 215(5):703-712. PubMed ID: 28007922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel modes of action of aminoglycoside antibiotics against Pseudomonas aeruginosa.
    Morris G; Brown MR
    Lancet; 1988 Jun; 1(8599):1359-61. PubMed ID: 2898043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial efficacy of quaternary bisammonium salts and the effect of their sub-MICs on Pseudomonas aeruginosa virulence factors.
    Hostacká A; Majtán V; Hybenová D
    Folia Microbiol (Praha); 1995; 40(3):283-7. PubMed ID: 8919934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced virulence in ciprofloxacin-resistant variants of Pseudomonas aeruginosa strains.
    Ravizzola G; Pirali F; Paolucci A; Terlenghi L; Peroni L; Colombi A; Turano A
    J Antimicrob Chemother; 1987 Dec; 20(6):825-9. PubMed ID: 3126177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase.
    Falciani C; Lozzi L; Scali S; Brunetti J; Bracci L; Pini A
    Amino Acids; 2014 May; 46(5):1403-7. PubMed ID: 24510250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statins inhibit in vitro virulence phenotypes of Pseudomonas aeruginosa.
    Hennessy E; Mooij MJ; Legendre C; Reen FJ; O'Callaghan J; Adams C; O'Gara F
    J Antibiot (Tokyo); 2013 Feb; 66(2):99-101. PubMed ID: 23149514
    [No Abstract]   [Full Text] [Related]  

  • 47. Blue light treatment of Pseudomonas aeruginosa: Strong bactericidal activity, synergism with antibiotics and inactivation of virulence factors.
    Fila G; Kawiak A; Grinholc MS
    Virulence; 2017 Aug; 8(6):938-958. PubMed ID: 27763824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antibacterial activity of 9 antibiotics in relation to serotype and enzyme production of Pseudomonas aeruginosa].
    Tsukiyama F; Katoh M; Iida T; Nakamura K; Watanabe T; Ikeda M; Muroki K; Fujiue Y; Kuwabara M
    Jpn J Antibiot; 1982 Dec; 35(12):2805-11. PubMed ID: 6820667
    [No Abstract]   [Full Text] [Related]  

  • 49. [Virulence factors of Pseudomonas aeruginosa in mice].
    Goto S; Miyazaki S; Ohno A
    Nihon Rinsho; 1991 Oct; 49(10):2227-32. PubMed ID: 1749077
    [No Abstract]   [Full Text] [Related]  

  • 50. [Influence of urine pH and cations on antimicrobial activities of penems].
    Kiyota H; Machida T; Onodera S; Suzuki H; Goto H; Takamizawa S; Mitani H; Kawahara M; Igarashi H; Endoh K
    Kansenshogaku Zasshi; 1993 May; 67(5):435-9. PubMed ID: 8320460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [MIC, sub-MIC of macrolide resistant bacteria--special reference to their quorum-sensing system].
    Tateda K; Ishii Y; Yamaguchi K
    Jpn J Antibiot; 2001 Dec; 54 Suppl C():109-12. PubMed ID: 12575433
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of quaternary ammonium salts and amine oxides on Pseudomonas aeruginosa.
    Majtán V; Majtánová L; Hostacká A; Hybenová D; Mlynarcik D
    Microbios; 1995; 84(338):41-51. PubMed ID: 8569525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of proteolytic enzyme on experimental infection of mice with Pseudomonas aeruginosa.
    Tamura Y; Suzuki S; Kijima M; Takahashi T; Nakamura M
    J Vet Med Sci; 1992 Jun; 54(3):597-9. PubMed ID: 1643183
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effects of macrolide antibiotics against mucoid Pseudomonas aeruginosa].
    Yokoiyama S
    Kansenshogaku Zasshi; 1990 Nov; 64(11):1439-46. PubMed ID: 2126800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lonicerin, an anti-algE flavonoid against Pseudomonas aeruginosa virulence screened from Shuanghuanglian formula by molecule docking based strategy.
    Xu Z; Li K; Pan T; Liu J; Li B; Li C; Wang S; Diao Y; Liu X
    J Ethnopharmacol; 2019 Jul; 239():111909. PubMed ID: 31026553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biogenic tellurium nanorods as a novel antivirulence agent inhibiting pyoverdine production in Pseudomonas aeruginosa.
    Mohanty A; Kathawala MH; Zhang J; Chen WN; Loo JS; Kjelleberg S; Yang L; Cao B
    Biotechnol Bioeng; 2014 May; 111(5):858-65. PubMed ID: 24222554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.
    Cryz SJ; Pitt TL; Fürer E; Germanier R
    Infect Immun; 1984 May; 44(2):508-13. PubMed ID: 6425224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enzymic and permeability activity of Pseudomonas aeruginosa after treatment with sub-MICs of organic ammonium salts.
    Hostacká A; Majtán V
    Folia Microbiol (Praha); 1994; 39(3):197-202. PubMed ID: 7995601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review of Anti-Bacterial Activities of Curcumin against Pseudomonas aeruginosa.
    Neyestani Z; Ebrahimi SA; Ghazaghi A; Jalili A; Sahebkar A; Rahimi HR
    Crit Rev Eukaryot Gene Expr; 2019; 29(5):377-385. PubMed ID: 32421995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ANALYSIS OF THE MODE OF ACTION OF A PSEUDOMONAS AERUGINOSA ANTI-PERSISTER COMPOUND.
    Defrayne V; Liebens V; Swings T; Corbau R; Marchand A; Chaltin P; Van Bambeke F; Anantharajah A; Fauvart M; Michiels J
    Commun Agric Appl Biol Sci; 2015; 80(1):137-43. PubMed ID: 26630768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.